Emerald Hills, CA, United States of America

Scott J Dylla

USPTO Granted Patents = 50 (Patent Applications = 20)

CIPO Patents = 5 (Patent Applications = 11)

EPO Patents = 7 (Patent Applications = 13)

Average Co-Inventor Count = 5.8

ph-index = 8

Forward Citations = 303(Granted Patents)

Forward Citations (Not Self Cited) = 294(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Mountain View, CA (US) (2010 - 2018)
Emerald Hills, CA (US) (2015 - 2021)

Company Filing History:

28 out of 40

Abbvie Stemcentrx LLC

University of Michigan

Oncomed Pharmaceuticals, Inc.

patents

6. 1 out of 5,303

Leland Stanford Junior University

patents

where one patent can have more than one assignee

Years Active: 2010-2021

Loading Chart...

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11033634 - Light chain variable regions (2021-06-15),

2. 10836831 - Anti-PTK7 antibodies and methods of use (2020-11-17),

3. 10533051 - Anti SEZ6 antibodies and methods of use (2020-01-14),

4. 10137204 - Anti-DLL3 antibody drug conjugates for treating cancer (2018-11-27),

5. 10087258 - Anti-CD324 monoclonal antibodies and uses thereof (2018-10-02),

6. 10017565 - Modulators and methods of use (2018-07-10),

7. 9969798 - Modulators and methods of use (2018-05-15),

8. 9945842 - Identification and enrichment of cell subpopulations (2018-04-17),

9. 9937268 - Anti-DLL3 antibody drug conjugates and methods of use (2018-04-10),

10. 9931421 - Methods of delivering DLL3 antibody drug conjugates (2018-04-03),

11. 9931420 - Methods of making DLL3 antibody drug conjugates (2018-04-03),

12. 9914784 - PTK7 modulators and methods of use (2018-03-13),

13. 9878053 - Methods of delivering DLL3 antibody drug conjugates (2018-01-30),

14. 9872922 - Anti-EFNA4 antibody-drug conjugates (2018-01-23),

15. 9867887 - Anti-DLL3 antibody drug conjugates (2018-01-16),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'd be delighted to help you with an article on inventor Scott J Dylla. Let's delve into the fascinating world of his contributions!

Title: The Inventive Journey of Scott J Dylla

Introduction:

Scott J Dylla, a prolific inventor based in Emerald Hills, CA, USA, has made significant strides in the field of patents with an impressive count of 50 to his name. His groundbreaking contributions have left an indelible mark on the realm of innovations.

Latest Patents:

His latest patents showcase his innovative prowess, including inventions such as "Light chain variable regions - Novel modulators" and "Anti-PTK7 antibodies and methods of use," which highlight his focus on addressing proliferative and hyperproliferative disorders with cutting-edge solutions.

Career Highlights:

Having worked with companies such as AbbVie Stemcentrx LLC and Stemcentrx, Inc., Scott J Dylla has honed his skills and expertise in turning innovative ideas into tangible solutions. His tenure with these esteemed organizations has further solidified his position as a trailblazer in the world of inventions.

Collaborations:

Throughout his career, Scott J Dylla has collaborated with esteemed professionals in the field, including notable coworkers like Robert A Stull and Orit Foord. These collaborations have not only enriched his inventive journey but have also paved the way for transformative breakthroughs in the industry.

Conclusion:

In conclusion, Scott J Dylla's unwavering dedication to innovation, coupled with his prolific patent portfolio and collaborative spirit, exemplifies the true essence of a visionary inventor. His contributions continue to inspire and drive advancements in the ever-evolving landscape of inventions.

This text is generated by artificial intelligence and may not be accurate.